Skip to content
Screener

Summit Therapeutics SMMT Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Immunome logo
ImmunomeIMNM
$446K-63.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2M-33.3%

Other financials

Income statement

See full
Revenue-
Operating income-$65.6M-81.2%
Net income-$189.4M-201%
EPS (diluted)-$0.24-167%

Balance sheet

See full
Cash & equivalents$8.2M+7.2%
Total debt$20.0M+211%
Total equity$545.9M+58.5%
Total assets$647.9M+68.8%

Cash flow

See full
Operating cash flow-$122.3M-99.9%
CapEx$245.0K-41.9%
Free cash flow-$122.5M-99.0%

Valuation

See full
Market cap$11.14B-46.9%
Enterprise value$11.15B-46.9%

Profitability

See full
Operating margin-268,266.8%-272,316pp
Net margin-271,685%-275,966pp
FCF margin-5,931.6%+4,730pp

Returns & leverage

See full
Return on equity-271%-1,725pp
Debt / equity0.0×
Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 5:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001599298-26-000039
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash flows from operating activities:
Net loss$(189,424)$(62,913)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount on short-term investments(4,217)(2,966)
Unrealized foreign exchange loss (gain)190(224)
Depreciation4425
Stock-based compensation72,79111,096
Change in operating assets and liabilities:

Item 1. Financial Statements.

FAQ

What is Summit Therapeutics's accretion (amortization) of discounts and premiums, investments?
Summit Therapeutics (SMMT) reported accretion (amortization) of discounts and premiums, investments of $4.22M in Q1 2026.
How has Summit Therapeutics's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Summit Therapeutics's accretion (amortization) of discounts and premiums, investments increased by 42.2% year-over-year, from $2.97M to $4.22M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to the carrying value of investment securities resulting from the amortization of premiums or accretion of discounts. It reflects the gradual adjustment of investment values toward their face value over time.

Ask your AI about Summit Therapeutics's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude